Brief: Cerenis Therapeutics Q3 Cash Holding of 12.9 Million Euros

Abionyx Pharma SA

25/10/2018 17:24

Oct 25 (Reuters) - CERENIS THERAPEUTICS HOLDING SA
 CEREN.PA :
    * CERENIS THERAPEUTICS ANNOUNCES ITS CASH POSITION FOR Q3
2018 AND
HIGHLIGHTS THE PROGRESS MADE OVER THE PERIOD AND KEY
PERSPECTIVES FOR THE END OF 2018
    * SOLID CASH POSITION OF EUR 12.9 MILLION AT 30 SEPTEMBER
2018
    * RESULTS FOR CER-209 ARE EXPECTED BY END OF H2 2018.
    * POSITIVE TANGO RESULTS COULD LEAD TO MARKET AUTHORIZATION
FILING
OF CER-001 BY END OF 2019.

Source text for Eikon:  urn:newsml:reuters.com:*:nBw1bg3bZa
Further company coverage:  CEREN.PA 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))